TEAD Inhibition in Combination to Tackle Targeted Therapy Resistance in Oncology •Evaluating the context in which the Hippo pathway confers resistance to targeted therapies •Considering potential pathways and drugs to use in combination with TEAD inhibit
Time: 4:15 pm
day: Conference Day One
Details:
- Evaluating the context in which the Hippo pathway confers resistance to targeted therapies
- Considering potential pathways and drugs to use in combination with TEAD inhibitors
- Exploring future steps at Ikena
